Vol 31 - N° 6 - décembre 2011
P. 415-480© Elsevier Masson SAS
Place du pathologiste dans la prise en charge des cancers en situation néoadjuvante
Page :i
The pathologist in neoadjuvant treatment of cancer: Faith or perceptiveness?
Page :415-416
David Azria
The pathologist’s place in the neoadjuvant management of cancer: A special issue
Page :417-418
Frédéric Bibeau
Role of the pathologist in the processing of adenocarcinoma of the stomach, oesophagogastric junction and lower third of the oesophagus
Page :419-426
Magali Svrcek, Jean-François Fléjou
Management of colorectal liver metastases after induction treatment. The pathologist’s role in 2011
Page :427-432
Frédéric Bibeau, Benjamin Rivière, Florence Boissière, Marie-Françoise Jourdan, Xavier Bodin, Véronique Perrault, Céline Cantos, Rosy Lavaill, Marc Ychou, François Quenet, Benoit Terris
Locally advanced rectal cancer managment: Which role for the pathologist in 2011?
Page :433-441
Frédéric Bibeau, Anne Rullier, Marie-Françoise Jourdan, Hélène Frugier, Julien Palasse, Cristina Leaha, Amélie Gudin de Vallerin, Benjamin Rivière, Xavier Bodin, Véronique Perrault, Céline Cantos, Roselyne Lavaill, Florence Boissière-Michot, David Azria, Pierre-Emmanuel Colombo, Philippe Rouanet, Éric Rullier, Yves Panis, Nathalie Guedj
Neoadjuvant treatment of breast cancer: Implications for the pathologist
Page :442-454
Sophie Le Guellec, Romain Perallon, Jean-Philippe Alunni, Hélène Charitansky, Christina Leaha, Aurélie Maran Gonzalez, Marie-Christine Chateau, Joelle Simony-Lafontaine, William Jacot, Marian Gutowski, Frédérique Penault-Llorca, Florence Dalenc, Magali Lacroix-Triki
Place of the pathologist in the management of primary bone tumors (osteosarcoma and Ewing’s family tumors after neoadjuvant treatment)
Page :455-465
Anne Gomez-Brouchet, Corinne Bouvier, Anne-Valérie Decouvelaere, Frédérique Larousserie, Sébastien Aubert, Xavier Leroy, Jean-Marc Guinebretière, Aurore Coulomb, Elisabeth Cassagnau, Anne de Muret, Virginie Audard, Béatrice Marie, Gonzague de Pinieux
The pathologist’s role in the neoadjuvant strategy of renal-cell carcinoma
Page :466-471
Xavier Leroy, Julien Edeline, Nathalie Rioux-Leclercq
HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): A comparative study with fluorescent in situ hybridization (FISH)
Page :472-479
Abbas Akhdar, Marc Bronsard, Renald Lemieux, Sameh Geha
Page :480